nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.372	1	CrCtD
Gemcitabine—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.116	0.498	CrCrCtD
Gemcitabine—SLC28A1—Stavudine—acquired immunodeficiency syndrome	0.0997	0.324	CbGbCtD
Gemcitabine—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.0611	0.262	CrCrCtD
Gemcitabine—SLC29A2—Didanosine—acquired immunodeficiency syndrome	0.0502	0.163	CbGbCtD
Gemcitabine—CMPK1—Lamivudine—acquired immunodeficiency syndrome	0.0425	0.138	CbGbCtD
Gemcitabine—SLC28A1—Zidovudine—acquired immunodeficiency syndrome	0.0397	0.129	CbGbCtD
Gemcitabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0294	0.126	CrCrCtD
Gemcitabine—SLC29A1—Didanosine—acquired immunodeficiency syndrome	0.0289	0.0936	CbGbCtD
Gemcitabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0266	0.114	CrCrCtD
Gemcitabine—SLC29A2—Zidovudine—acquired immunodeficiency syndrome	0.0264	0.0856	CbGbCtD
Gemcitabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.0109	0.0353	CbGbCtD
Gemcitabine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00164	0.00533	CbGbCtD
Gemcitabine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00148	0.00482	CbGbCtD
Gemcitabine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00416	CbGbCtD
Gemcitabine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00404	CbGbCtD
Gemcitabine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00365	CbGbCtD
Gemcitabine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00365	CbGbCtD
Gemcitabine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.0035	CbGbCtD
Gemcitabine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.000835	0.00271	CbGbCtD
Gemcitabine—SLC28A1—digestive system—acquired immunodeficiency syndrome	0.000639	0.024	CbGeAlD
Gemcitabine—POLD1—skin of body—acquired immunodeficiency syndrome	0.000532	0.02	CbGeAlD
Gemcitabine—POLD1—lymphoid tissue—acquired immunodeficiency syndrome	0.000431	0.0162	CbGeAlD
Gemcitabine—POLD1—digestive system—acquired immunodeficiency syndrome	0.000426	0.016	CbGeAlD
Gemcitabine—CMPK1—skin of body—acquired immunodeficiency syndrome	0.000425	0.0159	CbGeAlD
Gemcitabine—POLA1—retina—acquired immunodeficiency syndrome	0.000391	0.0147	CbGeAlD
Gemcitabine—SLC28A3—digestive system—acquired immunodeficiency syndrome	0.000391	0.0146	CbGeAlD
Gemcitabine—CDA—lymphoid tissue—acquired immunodeficiency syndrome	0.000387	0.0145	CbGeAlD
Gemcitabine—CDA—blood—acquired immunodeficiency syndrome	0.000364	0.0137	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—acquired immunodeficiency syndrome	0.00036	0.0135	CbGeAlD
Gemcitabine—POLD1—lung—acquired immunodeficiency syndrome	0.000356	0.0133	CbGeAlD
Gemcitabine—CDA—bone marrow—acquired immunodeficiency syndrome	0.000352	0.0132	CbGeAlD
Gemcitabine—CMPK1—lymphoid tissue—acquired immunodeficiency syndrome	0.000344	0.0129	CbGeAlD
Gemcitabine—SLC29A2—blood—acquired immunodeficiency syndrome	0.00034	0.0128	CbGeAlD
Gemcitabine—CMPK1—digestive system—acquired immunodeficiency syndrome	0.00034	0.0127	CbGeAlD
Gemcitabine—CDA—vagina—acquired immunodeficiency syndrome	0.000338	0.0127	CbGeAlD
Gemcitabine—RRM2—skin of body—acquired immunodeficiency syndrome	0.000328	0.0123	CbGeAlD
Gemcitabine—SLC28A3—lung—acquired immunodeficiency syndrome	0.000326	0.0122	CbGeAlD
Gemcitabine—CMPK1—blood—acquired immunodeficiency syndrome	0.000324	0.0121	CbGeAlD
Gemcitabine—POLE—lymphoid tissue—acquired immunodeficiency syndrome	0.000322	0.0121	CbGeAlD
Gemcitabine—POLE—digestive system—acquired immunodeficiency syndrome	0.000318	0.0119	CbGeAlD
Gemcitabine—SLC29A2—vagina—acquired immunodeficiency syndrome	0.000315	0.0118	CbGeAlD
Gemcitabine—CMPK1—bone marrow—acquired immunodeficiency syndrome	0.000313	0.0117	CbGeAlD
Gemcitabine—CMPK1—spinal cord—acquired immunodeficiency syndrome	0.000312	0.0117	CbGeAlD
Gemcitabine—RRM1—retina—acquired immunodeficiency syndrome	0.00031	0.0116	CbGeAlD
Gemcitabine—POLE—blood—acquired immunodeficiency syndrome	0.000303	0.0114	CbGeAlD
Gemcitabine—CMPK1—vagina—acquired immunodeficiency syndrome	0.0003	0.0113	CbGeAlD
Gemcitabine—POLE—bone marrow—acquired immunodeficiency syndrome	0.000294	0.011	CbGeAlD
Gemcitabine—CMPK1—lung—acquired immunodeficiency syndrome	0.000284	0.0106	CbGeAlD
Gemcitabine—POLE—vagina—acquired immunodeficiency syndrome	0.000281	0.0105	CbGeAlD
Gemcitabine—RRM1—skin of body—acquired immunodeficiency syndrome	0.000272	0.0102	CbGeAlD
Gemcitabine—POLE—lung—acquired immunodeficiency syndrome	0.000266	0.00997	CbGeAlD
Gemcitabine—RRM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000265	0.00995	CbGeAlD
Gemcitabine—CMPK1—nervous system—acquired immunodeficiency syndrome	0.000263	0.00985	CbGeAlD
Gemcitabine—RRM2—digestive system—acquired immunodeficiency syndrome	0.000262	0.00983	CbGeAlD
Gemcitabine—POLA1—blood—acquired immunodeficiency syndrome	0.000261	0.0098	CbGeAlD
Gemcitabine—CMPK1—central nervous system—acquired immunodeficiency syndrome	0.000253	0.00949	CbGeAlD
Gemcitabine—POLA1—bone marrow—acquired immunodeficiency syndrome	0.000253	0.00948	CbGeAlD
Gemcitabine—POLD1—brain—acquired immunodeficiency syndrome	0.000252	0.00944	CbGeAlD
Gemcitabine—RRM2—blood—acquired immunodeficiency syndrome	0.00025	0.00937	CbGeAlD
Gemcitabine—TYMS—skin of body—acquired immunodeficiency syndrome	0.000247	0.00926	CbGeAlD
Gemcitabine—POLE—nervous system—acquired immunodeficiency syndrome	0.000246	0.00923	CbGeAlD
Gemcitabine—POLD1—lymph node—acquired immunodeficiency syndrome	0.000243	0.00912	CbGeAlD
Gemcitabine—POLA1—vagina—acquired immunodeficiency syndrome	0.000242	0.00909	CbGeAlD
Gemcitabine—RRM2—bone marrow—acquired immunodeficiency syndrome	0.000242	0.00906	CbGeAlD
Gemcitabine—DCK—retina—acquired immunodeficiency syndrome	0.000241	0.00903	CbGeAlD
Gemcitabine—POLE—central nervous system—acquired immunodeficiency syndrome	0.000237	0.00889	CbGeAlD
Gemcitabine—RRM2—vagina—acquired immunodeficiency syndrome	0.000232	0.00868	CbGeAlD
Gemcitabine—POLA1—lung—acquired immunodeficiency syndrome	0.000229	0.00859	CbGeAlD
Gemcitabine—RRM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000221	0.00827	CbGeAlD
Gemcitabine—RRM2—lung—acquired immunodeficiency syndrome	0.000219	0.00821	CbGeAlD
Gemcitabine—CDA—lymph node—acquired immunodeficiency syndrome	0.000218	0.00819	CbGeAlD
Gemcitabine—RRM1—digestive system—acquired immunodeficiency syndrome	0.000218	0.00817	CbGeAlD
Gemcitabine—SLC29A2—brain—acquired immunodeficiency syndrome	0.000211	0.00792	CbGeAlD
Gemcitabine—RRM1—blood—acquired immunodeficiency syndrome	0.000208	0.00778	CbGeAlD
Gemcitabine—SLC29A2—lymph node—acquired immunodeficiency syndrome	0.000204	0.00765	CbGeAlD
Gemcitabine—RRM2—nervous system—acquired immunodeficiency syndrome	0.000203	0.0076	CbGeAlD
Gemcitabine—CMPK1—brain—acquired immunodeficiency syndrome	0.000201	0.00753	CbGeAlD
Gemcitabine—RRM1—bone marrow—acquired immunodeficiency syndrome	0.000201	0.00753	CbGeAlD
Gemcitabine—TYMS—lymphoid tissue—acquired immunodeficiency syndrome	0.0002	0.0075	CbGeAlD
Gemcitabine—RRM1—spinal cord—acquired immunodeficiency syndrome	0.0002	0.0075	CbGeAlD
Gemcitabine—TYMS—digestive system—acquired immunodeficiency syndrome	0.000198	0.0074	CbGeAlD
Gemcitabine—RRM2—central nervous system—acquired immunodeficiency syndrome	0.000195	0.00732	CbGeAlD
Gemcitabine—CMPK1—lymph node—acquired immunodeficiency syndrome	0.000194	0.00728	CbGeAlD
Gemcitabine—RRM1—vagina—acquired immunodeficiency syndrome	0.000192	0.00721	CbGeAlD
Gemcitabine—POLE—brain—acquired immunodeficiency syndrome	0.000188	0.00706	CbGeAlD
Gemcitabine—TYMS—blood—acquired immunodeficiency syndrome	0.000188	0.00705	CbGeAlD
Gemcitabine—TYMS—bone marrow—acquired immunodeficiency syndrome	0.000182	0.00683	CbGeAlD
Gemcitabine—RRM1—lung—acquired immunodeficiency syndrome	0.000182	0.00682	CbGeAlD
Gemcitabine—POLE—lymph node—acquired immunodeficiency syndrome	0.000182	0.00682	CbGeAlD
Gemcitabine—SLC29A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000179	0.00672	CbGeAlD
Gemcitabine—SLC29A1—digestive system—acquired immunodeficiency syndrome	0.000177	0.00664	CbGeAlD
Gemcitabine—TYMS—vagina—acquired immunodeficiency syndrome	0.000174	0.00654	CbGeAlD
Gemcitabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000171	0.00642	CbGeAlD
Gemcitabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000169	0.00634	CbGeAlD
Gemcitabine—SLC29A1—blood—acquired immunodeficiency syndrome	0.000169	0.00633	CbGeAlD
Gemcitabine—RRM1—nervous system—acquired immunodeficiency syndrome	0.000168	0.00632	CbGeAlD
Gemcitabine—TYMS—lung—acquired immunodeficiency syndrome	0.000165	0.00618	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—acquired immunodeficiency syndrome	0.000163	0.00612	CbGeAlD
Gemcitabine—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000163	0.00612	CbGeAlD
Gemcitabine—POLA1—brain—acquired immunodeficiency syndrome	0.000162	0.00608	CbGeAlD
Gemcitabine—RRM1—central nervous system—acquired immunodeficiency syndrome	0.000162	0.00608	CbGeAlD
Gemcitabine—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000161	0.00604	CbGeAlD
Gemcitabine—DCK—blood—acquired immunodeficiency syndrome	0.000161	0.00604	CbGeAlD
Gemcitabine—POLA1—lymph node—acquired immunodeficiency syndrome	0.000157	0.00588	CbGeAlD
Gemcitabine—SLC29A1—vagina—acquired immunodeficiency syndrome	0.000156	0.00586	CbGeAlD
Gemcitabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000156	0.00585	CbGeAlD
Gemcitabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.000155	0.00582	CbGeAlD
Gemcitabine—RRM2—brain—acquired immunodeficiency syndrome	0.000155	0.00581	CbGeAlD
Gemcitabine—ABCC10—blood—acquired immunodeficiency syndrome	0.000154	0.00576	CbGeAlD
Gemcitabine—TYMS—nervous system—acquired immunodeficiency syndrome	0.000153	0.00573	CbGeAlD
Gemcitabine—RRM2—lymph node—acquired immunodeficiency syndrome	0.00015	0.00562	CbGeAlD
Gemcitabine—DCK—vagina—acquired immunodeficiency syndrome	0.000149	0.0056	CbGeAlD
Gemcitabine—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000149	0.00557	CbGeAlD
Gemcitabine—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000148	0.00555	CbGeAlD
Gemcitabine—SLC29A1—lung—acquired immunodeficiency syndrome	0.000148	0.00555	CbGeAlD
Gemcitabine—TYMS—central nervous system—acquired immunodeficiency syndrome	0.000147	0.00551	CbGeAlD
Gemcitabine—ABCC10—vagina—acquired immunodeficiency syndrome	0.000142	0.00534	CbGeAlD
Gemcitabine—DCK—lung—acquired immunodeficiency syndrome	0.000141	0.0053	CbGeAlD
Gemcitabine—SLC29A1—nervous system—acquired immunodeficiency syndrome	0.000137	0.00514	CbGeAlD
Gemcitabine—ABCC10—lung—acquired immunodeficiency syndrome	0.000135	0.00505	CbGeAlD
Gemcitabine—SLC29A1—central nervous system—acquired immunodeficiency syndrome	0.000132	0.00494	CbGeAlD
Gemcitabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000131	0.00491	CbGeAlD
Gemcitabine—RRM1—brain—acquired immunodeficiency syndrome	0.000129	0.00483	CbGeAlD
Gemcitabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000126	0.00472	CbGeAlD
Gemcitabine—RRM1—lymph node—acquired immunodeficiency syndrome	0.000124	0.00466	CbGeAlD
Gemcitabine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000121	0.00454	CbGeAlD
Gemcitabine—TYMS—brain—acquired immunodeficiency syndrome	0.000117	0.00438	CbGeAlD
Gemcitabine—TYMS—lymph node—acquired immunodeficiency syndrome	0.000113	0.00423	CbGeAlD
Gemcitabine—SLC29A1—brain—acquired immunodeficiency syndrome	0.000105	0.00393	CbGeAlD
Gemcitabine—SLC29A1—lymph node—acquired immunodeficiency syndrome	0.000101	0.00379	CbGeAlD
Gemcitabine—DCK—brain—acquired immunodeficiency syndrome	0.0001	0.00375	CbGeAlD
Gemcitabine—DCK—lymph node—acquired immunodeficiency syndrome	9.66e-05	0.00362	CbGeAlD
Gemcitabine—ABCC10—brain—acquired immunodeficiency syndrome	9.53e-05	0.00357	CbGeAlD
Gemcitabine—ABCC10—lymph node—acquired immunodeficiency syndrome	9.21e-05	0.00345	CbGeAlD
Gemcitabine—ABCB1—retina—acquired immunodeficiency syndrome	6.63e-05	0.00249	CbGeAlD
Gemcitabine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	4.71e-05	0.00177	CbGeAlD
Gemcitabine—ABCB1—digestive system—acquired immunodeficiency syndrome	4.65e-05	0.00175	CbGeAlD
Gemcitabine—ABCB1—blood—acquired immunodeficiency syndrome	4.43e-05	0.00166	CbGeAlD
Gemcitabine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000735	CcSEcCtD
Gemcitabine—Back pain—Saquinavir—acquired immunodeficiency syndrome	4.42e-05	0.000734	CcSEcCtD
Gemcitabine—Anorexia—Indinavir—acquired immunodeficiency syndrome	4.41e-05	0.000734	CcSEcCtD
Gemcitabine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	4.4e-05	0.000732	CcSEcCtD
Gemcitabine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	4.38e-05	0.000729	CcSEcCtD
Gemcitabine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000726	CcSEcCtD
Gemcitabine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000726	CcSEcCtD
Gemcitabine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000726	CcSEcCtD
Gemcitabine—Erythema—Lamivudine—acquired immunodeficiency syndrome	4.36e-05	0.000724	CcSEcCtD
Gemcitabine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	4.33e-05	0.000719	CcSEcCtD
Gemcitabine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	4.31e-05	0.000717	CcSEcCtD
Gemcitabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	4.3e-05	0.000715	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	4.3e-05	0.000715	CcSEcCtD
Gemcitabine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	4.29e-05	0.000714	CcSEcCtD
Gemcitabine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	4.29e-05	0.000713	CcSEcCtD
Gemcitabine—ABCB1—bone marrow—acquired immunodeficiency syndrome	4.29e-05	0.00161	CbGeAlD
Gemcitabine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	4.28e-05	0.000712	CcSEcCtD
Gemcitabine—Malaise—Ritonavir—acquired immunodeficiency syndrome	4.28e-05	0.000711	CcSEcCtD
Gemcitabine—ABCB1—spinal cord—acquired immunodeficiency syndrome	4.27e-05	0.0016	CbGeAlD
Gemcitabine—Constipation—Zidovudine—acquired immunodeficiency syndrome	4.26e-05	0.000708	CcSEcCtD
Gemcitabine—Pain—Zidovudine—acquired immunodeficiency syndrome	4.26e-05	0.000708	CcSEcCtD
Gemcitabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	4.26e-05	0.000708	CcSEcCtD
Gemcitabine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	4.25e-05	0.000706	CcSEcCtD
Gemcitabine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	4.25e-05	0.000706	CcSEcCtD
Gemcitabine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	4.24e-05	0.000704	CcSEcCtD
Gemcitabine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	4.23e-05	0.000703	CcSEcCtD
Gemcitabine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	4.22e-05	0.000701	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	4.22e-05	0.000701	CcSEcCtD
Gemcitabine—Back pain—Lamivudine—acquired immunodeficiency syndrome	4.21e-05	0.0007	CcSEcCtD
Gemcitabine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	4.2e-05	0.000698	CcSEcCtD
Gemcitabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	4.2e-05	0.000697	CcSEcCtD
Gemcitabine—Insomnia—Indinavir—acquired immunodeficiency syndrome	4.19e-05	0.000696	CcSEcCtD
Gemcitabine—Oedema—Delavirdine—acquired immunodeficiency syndrome	4.19e-05	0.000696	CcSEcCtD
Gemcitabine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	4.17e-05	0.000693	CcSEcCtD
Gemcitabine—Rash—Didanosine—acquired immunodeficiency syndrome	4.16e-05	0.000692	CcSEcCtD
Gemcitabine—Infection—Delavirdine—acquired immunodeficiency syndrome	4.16e-05	0.000691	CcSEcCtD
Gemcitabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	4.16e-05	0.000691	CcSEcCtD
Gemcitabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	4.16e-05	0.000691	CcSEcCtD
Gemcitabine—Cough—Ritonavir—acquired immunodeficiency syndrome	4.14e-05	0.000688	CcSEcCtD
Gemcitabine—Headache—Didanosine—acquired immunodeficiency syndrome	4.13e-05	0.000687	CcSEcCtD
Gemcitabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	4.13e-05	0.000686	CcSEcCtD
Gemcitabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	4.12e-05	0.000685	CcSEcCtD
Gemcitabine—Malaise—Saquinavir—acquired immunodeficiency syndrome	4.12e-05	0.000684	CcSEcCtD
Gemcitabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	4.12e-05	0.000684	CcSEcCtD
Gemcitabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	4.11e-05	0.000683	CcSEcCtD
Gemcitabine—ABCB1—vagina—acquired immunodeficiency syndrome	4.11e-05	0.00154	CbGeAlD
Gemcitabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	4.1e-05	0.000682	CcSEcCtD
Gemcitabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	4.1e-05	0.000681	CcSEcCtD
Gemcitabine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	4.1e-05	0.000681	CcSEcCtD
Gemcitabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	4.09e-05	0.000679	CcSEcCtD
Gemcitabine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	4.07e-05	0.000676	CcSEcCtD
Gemcitabine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	4.07e-05	0.000676	CcSEcCtD
Gemcitabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	4.06e-05	0.000675	CcSEcCtD
Gemcitabine—Pruritus—Stavudine—acquired immunodeficiency syndrome	4.05e-05	0.000674	CcSEcCtD
Gemcitabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	4.05e-05	0.000673	CcSEcCtD
Gemcitabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	4.05e-05	0.000673	CcSEcCtD
Gemcitabine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	4.04e-05	0.000672	CcSEcCtD
Gemcitabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000671	CcSEcCtD
Gemcitabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000671	CcSEcCtD
Gemcitabine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000671	CcSEcCtD
Gemcitabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	4.03e-05	0.000669	CcSEcCtD
Gemcitabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	4.03e-05	0.000669	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	4.01e-05	0.000667	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	4e-05	0.000665	CcSEcCtD
Gemcitabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.99e-05	0.000664	CcSEcCtD
Gemcitabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.99e-05	0.000664	CcSEcCtD
Gemcitabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.99e-05	0.000663	CcSEcCtD
Gemcitabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.99e-05	0.000663	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.99e-05	0.000663	CcSEcCtD
Gemcitabine—Cough—Saquinavir—acquired immunodeficiency syndrome	3.98e-05	0.000662	CcSEcCtD
Gemcitabine—Pain—Indinavir—acquired immunodeficiency syndrome	3.96e-05	0.000658	CcSEcCtD
Gemcitabine—Constipation—Indinavir—acquired immunodeficiency syndrome	3.96e-05	0.000658	CcSEcCtD
Gemcitabine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.96e-05	0.000658	CcSEcCtD
Gemcitabine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.94e-05	0.000655	CcSEcCtD
Gemcitabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.94e-05	0.000654	CcSEcCtD
Gemcitabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.93e-05	0.000654	CcSEcCtD
Gemcitabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000653	CcSEcCtD
Gemcitabine—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000653	CcSEcCtD
Gemcitabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.92e-05	0.000652	CcSEcCtD
Gemcitabine—Nausea—Didanosine—acquired immunodeficiency syndrome	3.92e-05	0.000651	CcSEcCtD
Gemcitabine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.91e-05	0.00065	CcSEcCtD
Gemcitabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.9e-05	0.000648	CcSEcCtD
Gemcitabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.9e-05	0.000648	CcSEcCtD
Gemcitabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.89e-05	0.000647	CcSEcCtD
Gemcitabine—ABCB1—lung—acquired immunodeficiency syndrome	3.89e-05	0.00146	CbGeAlD
Gemcitabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000646	CcSEcCtD
Gemcitabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000646	CcSEcCtD
Gemcitabine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000646	CcSEcCtD
Gemcitabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.87e-05	0.000643	CcSEcCtD
Gemcitabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.86e-05	0.000642	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.86e-05	0.000642	CcSEcCtD
Gemcitabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.84e-05	0.000638	CcSEcCtD
Gemcitabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.82e-05	0.000634	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.81e-05	0.000634	CcSEcCtD
Gemcitabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000632	CcSEcCtD
Gemcitabine—Cough—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.000632	CcSEcCtD
Gemcitabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.8e-05	0.000631	CcSEcCtD
Gemcitabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.00063	CcSEcCtD
Gemcitabine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.79e-05	0.000629	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.78e-05	0.000628	CcSEcCtD
Gemcitabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.77e-05	0.000627	CcSEcCtD
Gemcitabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.77e-05	0.000627	CcSEcCtD
Gemcitabine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.76e-05	0.000625	CcSEcCtD
Gemcitabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000625	CcSEcCtD
Gemcitabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000622	CcSEcCtD
Gemcitabine—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.74e-05	0.000622	CcSEcCtD
Gemcitabine—Pain—Efavirenz—acquired immunodeficiency syndrome	3.74e-05	0.000622	CcSEcCtD
Gemcitabine—Rash—Nevirapine—acquired immunodeficiency syndrome	3.74e-05	0.000622	CcSEcCtD
Gemcitabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.74e-05	0.000621	CcSEcCtD
Gemcitabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.73e-05	0.00062	CcSEcCtD
Gemcitabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000619	CcSEcCtD
Gemcitabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.72e-05	0.000619	CcSEcCtD
Gemcitabine—Headache—Nevirapine—acquired immunodeficiency syndrome	3.72e-05	0.000618	CcSEcCtD
Gemcitabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000616	CcSEcCtD
Gemcitabine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000616	CcSEcCtD
Gemcitabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000616	CcSEcCtD
Gemcitabine—Infection—Saquinavir—acquired immunodeficiency syndrome	3.7e-05	0.000615	CcSEcCtD
Gemcitabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000613	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.68e-05	0.000612	CcSEcCtD
Gemcitabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.66e-05	0.000609	CcSEcCtD
Gemcitabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.66e-05	0.000608	CcSEcCtD
Gemcitabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000607	CcSEcCtD
Gemcitabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.65e-05	0.000607	CcSEcCtD
Gemcitabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000606	CcSEcCtD
Gemcitabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.64e-05	0.000605	CcSEcCtD
Gemcitabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.64e-05	0.000605	CcSEcCtD
Gemcitabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.62e-05	0.000602	CcSEcCtD
Gemcitabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.62e-05	0.000602	CcSEcCtD
Gemcitabine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.000602	CcSEcCtD
Gemcitabine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3.62e-05	0.000601	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.61e-05	0.000601	CcSEcCtD
Gemcitabine—Rash—Stavudine—acquired immunodeficiency syndrome	3.61e-05	0.0006	CcSEcCtD
Gemcitabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.61e-05	0.0006	CcSEcCtD
Gemcitabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.61e-05	0.0006	CcSEcCtD
Gemcitabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.61e-05	0.000599	CcSEcCtD
Gemcitabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000599	CcSEcCtD
Gemcitabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.6e-05	0.000598	CcSEcCtD
Gemcitabine—ABCB1—nervous system—acquired immunodeficiency syndrome	3.6e-05	0.00135	CbGeAlD
Gemcitabine—Headache—Stavudine—acquired immunodeficiency syndrome	3.59e-05	0.000597	CcSEcCtD
Gemcitabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.59e-05	0.000596	CcSEcCtD
Gemcitabine—Pain—Delavirdine—acquired immunodeficiency syndrome	3.58e-05	0.000595	CcSEcCtD
Gemcitabine—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.58e-05	0.000595	CcSEcCtD
Gemcitabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.57e-05	0.000594	CcSEcCtD
Gemcitabine—Rash—Abacavir—acquired immunodeficiency syndrome	3.56e-05	0.000591	CcSEcCtD
Gemcitabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.56e-05	0.000591	CcSEcCtD
Gemcitabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	3.55e-05	0.000591	CcSEcCtD
Gemcitabine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.55e-05	0.000591	CcSEcCtD
Gemcitabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.55e-05	0.00059	CcSEcCtD
Gemcitabine—Headache—Abacavir—acquired immunodeficiency syndrome	3.54e-05	0.000588	CcSEcCtD
Gemcitabine—Infection—Lamivudine—acquired immunodeficiency syndrome	3.53e-05	0.000587	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000586	CcSEcCtD
Gemcitabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.52e-05	0.000586	CcSEcCtD
Gemcitabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.52e-05	0.000586	CcSEcCtD
Gemcitabine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.5e-05	0.000582	CcSEcCtD
Gemcitabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.49e-05	0.000579	CcSEcCtD
Gemcitabine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	3.48e-05	0.000579	CcSEcCtD
Gemcitabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.000578	CcSEcCtD
Gemcitabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000578	CcSEcCtD
Gemcitabine—ABCB1—central nervous system—acquired immunodeficiency syndrome	3.47e-05	0.0013	CbGeAlD
Gemcitabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.46e-05	0.000575	CcSEcCtD
Gemcitabine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000574	CcSEcCtD
Gemcitabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.45e-05	0.000574	CcSEcCtD
Gemcitabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.45e-05	0.000573	CcSEcCtD
Gemcitabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.44e-05	0.000572	CcSEcCtD
Gemcitabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000571	CcSEcCtD
Gemcitabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.41e-05	0.000567	CcSEcCtD
Gemcitabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.41e-05	0.000566	CcSEcCtD
Gemcitabine—Nausea—Stavudine—acquired immunodeficiency syndrome	3.4e-05	0.000566	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000564	CcSEcCtD
Gemcitabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000563	CcSEcCtD
Gemcitabine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.37e-05	0.00056	CcSEcCtD
Gemcitabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.37e-05	0.000559	CcSEcCtD
Gemcitabine—Nausea—Abacavir—acquired immunodeficiency syndrome	3.35e-05	0.000557	CcSEcCtD
Gemcitabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000556	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.34e-05	0.000556	CcSEcCtD
Gemcitabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.34e-05	0.000555	CcSEcCtD
Gemcitabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.32e-05	0.000552	CcSEcCtD
Gemcitabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.32e-05	0.000552	CcSEcCtD
Gemcitabine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	3.32e-05	0.000552	CcSEcCtD
Gemcitabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.000551	CcSEcCtD
Gemcitabine—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.31e-05	0.00055	CcSEcCtD
Gemcitabine—Pain—Ritonavir—acquired immunodeficiency syndrome	3.31e-05	0.00055	CcSEcCtD
Gemcitabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.31e-05	0.00055	CcSEcCtD
Gemcitabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.28e-05	0.000545	CcSEcCtD
Gemcitabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.24e-05	0.000538	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000538	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.22e-05	0.000535	CcSEcCtD
Gemcitabine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000534	CcSEcCtD
Gemcitabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000534	CcSEcCtD
Gemcitabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000531	CcSEcCtD
Gemcitabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	3.19e-05	0.00053	CcSEcCtD
Gemcitabine—Constipation—Saquinavir—acquired immunodeficiency syndrome	3.19e-05	0.00053	CcSEcCtD
Gemcitabine—Pain—Saquinavir—acquired immunodeficiency syndrome	3.19e-05	0.00053	CcSEcCtD
Gemcitabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	3.17e-05	0.000527	CcSEcCtD
Gemcitabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	3.17e-05	0.000527	CcSEcCtD
Gemcitabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	3.17e-05	0.000526	CcSEcCtD
Gemcitabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000525	CcSEcCtD
Gemcitabine—Rash—Zidovudine—acquired immunodeficiency syndrome	3.14e-05	0.000522	CcSEcCtD
Gemcitabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.14e-05	0.000522	CcSEcCtD
Gemcitabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.14e-05	0.000521	CcSEcCtD
Gemcitabine—Headache—Zidovudine—acquired immunodeficiency syndrome	3.12e-05	0.000518	CcSEcCtD
Gemcitabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.1e-05	0.000515	CcSEcCtD
Gemcitabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000514	CcSEcCtD
Gemcitabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.07e-05	0.00051	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.07e-05	0.00051	CcSEcCtD
Gemcitabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000509	CcSEcCtD
Gemcitabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.06e-05	0.000509	CcSEcCtD
Gemcitabine—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.04e-05	0.000505	CcSEcCtD
Gemcitabine—Pain—Lamivudine—acquired immunodeficiency syndrome	3.04e-05	0.000505	CcSEcCtD
Gemcitabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3e-05	0.000499	CcSEcCtD
Gemcitabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.99e-05	0.000498	CcSEcCtD
Gemcitabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.96e-05	0.000492	CcSEcCtD
Gemcitabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.96e-05	0.000492	CcSEcCtD
Gemcitabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.95e-05	0.00049	CcSEcCtD
Gemcitabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.94e-05	0.000489	CcSEcCtD
Gemcitabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.93e-05	0.000487	CcSEcCtD
Gemcitabine—Rash—Indinavir—acquired immunodeficiency syndrome	2.92e-05	0.000485	CcSEcCtD
Gemcitabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.92e-05	0.000485	CcSEcCtD
Gemcitabine—Headache—Indinavir—acquired immunodeficiency syndrome	2.9e-05	0.000482	CcSEcCtD
Gemcitabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.86e-05	0.000476	CcSEcCtD
Gemcitabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.81e-05	0.000467	CcSEcCtD
Gemcitabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000462	CcSEcCtD
Gemcitabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.78e-05	0.000462	CcSEcCtD
Gemcitabine—Rash—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.000459	CcSEcCtD
Gemcitabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.000458	CcSEcCtD
Gemcitabine—ABCB1—brain—acquired immunodeficiency syndrome	2.75e-05	0.00103	CbGeAlD
Gemcitabine—Nausea—Indinavir—acquired immunodeficiency syndrome	2.75e-05	0.000457	CcSEcCtD
Gemcitabine—Headache—Efavirenz—acquired immunodeficiency syndrome	2.74e-05	0.000456	CcSEcCtD
Gemcitabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.74e-05	0.000455	CcSEcCtD
Gemcitabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000444	CcSEcCtD
Gemcitabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.000442	CcSEcCtD
Gemcitabine—ABCB1—lymph node—acquired immunodeficiency syndrome	2.66e-05	0.000997	CbGeAlD
Gemcitabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.65e-05	0.00044	CcSEcCtD
Gemcitabine—Rash—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000439	CcSEcCtD
Gemcitabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000438	CcSEcCtD
Gemcitabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.64e-05	0.000438	CcSEcCtD
Gemcitabine—Headache—Delavirdine—acquired immunodeficiency syndrome	2.62e-05	0.000436	CcSEcCtD
Gemcitabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.6e-05	0.000432	CcSEcCtD
Gemcitabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.55e-05	0.000424	CcSEcCtD
Gemcitabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.55e-05	0.000424	CcSEcCtD
Gemcitabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.51e-05	0.000418	CcSEcCtD
Gemcitabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.49e-05	0.000413	CcSEcCtD
Gemcitabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000409	CcSEcCtD
Gemcitabine—Rash—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000406	CcSEcCtD
Gemcitabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000405	CcSEcCtD
Gemcitabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.43e-05	0.000404	CcSEcCtD
Gemcitabine—Headache—Ritonavir—acquired immunodeficiency syndrome	2.43e-05	0.000403	CcSEcCtD
Gemcitabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000394	CcSEcCtD
Gemcitabine—Rash—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.00039	CcSEcCtD
Gemcitabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.00039	CcSEcCtD
Gemcitabine—Headache—Saquinavir—acquired immunodeficiency syndrome	2.33e-05	0.000388	CcSEcCtD
Gemcitabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.3e-05	0.000382	CcSEcCtD
Gemcitabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000376	CcSEcCtD
Gemcitabine—Rash—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000373	CcSEcCtD
Gemcitabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000372	CcSEcCtD
Gemcitabine—Headache—Lamivudine—acquired immunodeficiency syndrome	2.23e-05	0.00037	CcSEcCtD
Gemcitabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.21e-05	0.000368	CcSEcCtD
Gemcitabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.11e-05	0.000351	CcSEcCtD
